https://www.selleckchem.com/pr....oducts/nazartinib-eg
The most common grade 3/4 TRAEs were leukopenia (70%), neutropenia (70%), lymphopenia (61%), anemia (57%), and alanine transaminase increase (43%). One treatment-related dose-limiting toxicity (grade 3 syncope) occurred. Twelve patients achieved a partial response and 1 achieved a complete response. Responses to all four regimens were observed in ovarian and endometrial cancers. Combination selinexor + CP was safe and tolerated in advanced ovarian and endometrial cancers. Combination selinexor + CP was safe and tolerat
إعجاب
علق
شارك
